Emergence of Cytotoxic Resistance in Cancer Cell Populations: Single-cell Mechanisms and Population-level Consequences

被引:0
作者
Lorenzi, Tommaso [1 ,2 ]
Chisholm, Rebecca H. [3 ]
Lorz, Alexander [2 ,4 ,5 ]
Larsen, Annette K. [6 ,7 ]
de Almeida, Luis Neves [2 ,4 ,5 ]
Escargueil, Alexandre [6 ,7 ]
Clairambault, Jean [2 ,4 ,5 ]
机构
[1] ENS Cachan, CNRS, Ctr Math & Leurs Applicat, F-94230 Cachan, France
[2] INRIA Paris Rocquencourt, MAMBA Team, BP105, F-78153 Le Chesnay, France
[3] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia
[4] Univ Paris 06, Sorbonne Univ, UMR 7598, Lab Jacques Louis Lions, F-75005 Paris, France
[5] CNRS, UMR 7598, Lab Jacques Louis Lions, F-75005 Paris, France
[6] Univ Paris 06, Sorbonne Univ, F-75005 Paris, France
[7] INSERM, UMR S 938, Lab Canc Biol & Therapeut, F-75012 Paris, France
来源
PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON NUMERICAL ANALYSIS AND APPLIED MATHEMATICS 2015 (ICNAAM-2015) | 2016年 / 1738卷
关键词
Cancer modeling; reversible drug tolerance; phenotype evolution; non-genetic instability; stress-induced adaptation; MATHEMATICAL-MODEL; EVOLUTION; DYNAMICS; THERAPY;
D O I
10.1063/1.4952112
中图分类号
O29 [应用数学];
学科分类号
070104 ;
摘要
We formulate an individual-based model and a population model of phenotypic evolution, under cytotoxic drugs, in a cancer cell population structured by the expression levels of survival-potential and proliferation-potential. We apply these models to a recently studied experimental system. Our results suggest that mechanisms based on fundamental laws of biology can reversibly push an actively-proliferating, and drug-sensitive, cell population to transition into a weakly-proliferative and drug-tolerant state, which will eventually facilitate the emergence of more potent, proliferating and drug-tolerant cells.
引用
收藏
页数:4
相关论文
共 22 条
  • [1] Life history trade-offs in cancer evolution
    Aktipis, C. Athena
    Boddy, Amy M.
    Gatenby, Robert A.
    Brown, Joel S.
    Maley, Carlo C.
    [J]. NATURE REVIEWS CANCER, 2013, 13 (12) : 883 - 892
  • [2] Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment
    Anderson, Alexander R. A.
    Weaver, Alissa M.
    Cummings, Peter T.
    Quaranta, Vito
    [J]. CELL, 2006, 127 (05) : 905 - 915
  • [3] Spontaneous epigenetic variation in the Arabidopsis thaliana methylome
    Becker, Claude
    Hagmann, Joerg
    Mueller, Jonas
    Koenig, Daniel
    Stegle, Oliver
    Borgwardt, Karsten
    Weigel, Detlef
    [J]. NATURE, 2011, 480 (7376) : 245 - U127
  • [4] Gene Expression Noise Facilitates Adaptation and Drug Resistance Independently of Mutation
    Charlebois, Daniel A.
    Abdennur, Nezar
    Kaern, Mads
    [J]. PHYSICAL REVIEW LETTERS, 2011, 107 (21)
  • [5] Emergence of Drug Tolerance in Cancer Cell Populations: An Evolutionary Outcome of Selection, Nongenetic Instability, and Stress-Induced Adaptation
    Chisholm, Rebecca H.
    Lorenzi, Tommaso
    Lorz, Alexander
    Larsen, Annette K.
    de Almeida, Luis Neves
    Escargueil, Alexandre
    Clairambault, Jean
    [J]. CANCER RESEARCH, 2015, 75 (06) : 930 - 939
  • [6] Mechanism-Based Epigenetic Chemosensitization Therapy of Diffuse Large B-Cell Lymphoma
    Clozel, Thomas
    Yang, ShaoNing
    Elstrom, Rebecca L.
    Tam, Wayne
    Martin, Peter
    Kormaksson, Matthias
    Banerjee, Samprit
    Vasanthakumar, Aparna
    Culjkovic, Biljana
    Scott, David W.
    Wyman, Sarah
    Leser, Micheal
    Shaknovich, Rita
    Chadburn, Amy
    Tabbo, Fabrizio
    Godley, Lucy A.
    Gascoyne, Randy D.
    Borden, Katherine L.
    Inghirami, Giorgio
    Leonard, John P.
    Melnick, Ari
    Cerchietti, Leandro
    [J]. CANCER DISCOVERY, 2013, 3 (09) : 1002 - 1019
  • [7] A mathematical model for the dynamics of cancer hepatocytes under therapeutic actions
    Delitala, Marcello
    Lorenzi, Tommaso
    [J]. JOURNAL OF THEORETICAL BIOLOGY, 2012, 297 : 88 - 102
  • [8] Causes and consequences of increased glucose metabolism of cancers
    Gillies, Robert J.
    Robey, Ian
    Gatenby, Robert A.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2008, 49 : 24S - 42S
  • [9] Mechanisms of cancer drug resistance
    Gottesman, MM
    [J]. ANNUAL REVIEW OF MEDICINE, 2002, 53 : 615 - 627
  • [10] Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non-Small Cell Lung Cancer
    Juergens, Rosalyn A.
    Wrangle, John
    Vendetti, Frank P.
    Murphy, Sara C.
    Zhao, Ming
    Coleman, Barbara
    Sebree, Rosa
    Rodgers, Kristen
    Hooker, Craig M.
    Franco, Noreli
    Lee, Beverly
    Tsai, Salina
    Delgado, Igor Espinoza
    Rudek, Michelle A.
    Belinsky, Steven A.
    Herman, James G.
    Baylin, Stephen B.
    Brock, Malcolm V.
    Rudin, Charles M.
    [J]. CANCER DISCOVERY, 2011, 1 (07) : 598 - 607